CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 21.81
  • +0.46+2.15%
Trading Oct 17 13:36 CST
13.45BMarket Cap40.84P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Guojian Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.334B--
--2024/FY-- / 1.263B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.334B--
--2024/FY-- / 1.263B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--

Unlock Free Earnings Estimates

Sunshine Guojian Pharmaceutical Earnings Reports

  • Sunshine Guojian Pharmaceutical: Half-year report for the year 2024.

    Aug 22 12:00 ET

  • Sunshine Guojian Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 22 12:00 ET

  • Sansei Guojian: Report for the first quarter of 2024

    Apr 25 12:00 ET

  • Kokuken Mitsubo: Summary of the 2023 Annual Report

    Mar 20 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 17, 2024

    Buy

    • Strong Buy

      33.33%

    • Buy

      66.67%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data